Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety

INTRODUCTION: The intraocular pressure (IOP)-lowering effect and safety of tafluprost 0.0015%/timolol maleate 0.5% combination ophthalmic solution (Taf–TFC) were investigated in a real-world clinical setting. METHODS: A prospective up to 2-year (more than 1 year) observational study has been initiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Takagi, Yasutaka, Osaki, Hirotaka, Yamashita, Tomohiro, Kai, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125119/
https://www.ncbi.nlm.nih.gov/pubmed/27492380
http://dx.doi.org/10.1007/s40123-016-0057-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5125119/
https://www.ncbi.nlm.nih.gov/pubmed/27492380
http://dx.doi.org/10.1007/s40123-016-0057-3

Ejemplares similares